STOCK TITAN

Aura Biosciences: Montanova reports 2.9% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Aura Biosciences, Inc. (AURA) reported that Montanova Capital, LLC and Aaron Cowen each beneficially owned 2,973,971 shares, or 2.9% of the class, while Averill Master Fund, Ltd. reported 2,535,780 shares, or 2.4%. Each reported shared voting and dispositive power over its stated amount, with no sole voting or dispositive power.

The reported amounts include common stock that may be acquired under pre-funded warrants. Those warrants may be exercised only to the extent post-exercise beneficial ownership does not exceed 9.99%; the Fund may change its limit by written notice to a level no higher than 19.99%.

Montanova Capital and Aaron Cowen beneficial ownership 2,973,971 shares each Each reported 2.9% of the class.
Averill Master Fund beneficial ownership 2,535,780 shares Reported as 2.4% of the class.
Montanova Capital and Aaron Cowen ownership percentage 2.9% each Each reported beneficial ownership of 2,973,971 shares.
Averill Master Fund ownership percentage 2.4% Reported beneficial ownership of 2,535,780 shares.
Pre-funded warrant exercise price $0.00001 per share Warrants have no expiration date.
Beneficial-ownership limit 9.99% Maximum ownership after exercise under the applicable warrant limit.
Maximum adjusted beneficial-ownership limit 19.99% The Fund may change its limit by written notice; an increase takes effect on the 61st day after notice is delivered.
Pre-Funded Warrants financial
"exercise of pre-funded warrants with no expiration date"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
Maximum Percentage regulatory
"the “Maximum Percentage”"
Rule 13d-3 regulatory
"for purposes of Rule 13d-3 under the Exchange Act"
Rule 13d-3 defines who is treated as the beneficial owner of a company’s shares for U.S. securities disclosure rules — essentially anyone who has the power to vote or direct how shares are voted, or the power to buy or sell them, even if they don’t hold the certificates. For investors this matters because crossing certain ownership thresholds triggers public filing and disclosure obligations and signals potential control or influence, much like having the keys to a car implies you can drive it even if it’s registered to someone else.
shared dispositive power technical
"Shared Dispositive Power"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AURA shares did the reporting persons beneficially own?

Montanova Capital, LLC and Aaron Cowen each reported beneficial ownership of 2,973,971 AURA shares, or 2.9%, while Averill Master Fund, Ltd. reported 2,535,780 shares, or 2.4%. Each reported shared voting and dispositive power over its stated amount.

What are the terms of Averill Master Fund’s AURA pre-funded warrants?

The pre-funded warrants have no expiration date and an exercise price of $0.00001 per share. Exercise is limited so that the holders, their affiliates and members of any applicable Section 13(d) group do not exceed the applicable beneficial-ownership cap after exercise. An increase to that cap takes effect on the 61st day after notice is delivered.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





05153U107

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Montanova Capital, LLC
Signature:/s/ Andrew Nathanson
Name/Title:Andrew Nathanson, General Counsel and Chief Compliance Officer
Date:11/13/2026
Averill Master Fund, Ltd.
Signature:/s/ Andrew Nathanson
Name/Title:Andrew Nathanson, Authorized Signatory
Date:11/13/2026
Aaron Cowen
Signature:/s/ Aaron Cowen
Name/Title:Aaron Cowen
Date:11/13/2026

Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.
Exhibit Information

Exhibit A - Joint Filing Agreement Exhibit B - Control Person Identification

Keep reading